Try our Advanced Search for more refined results

Deals Rumor Mill: Baxalta, TPG Capital, Femsa

By Benjamin Horney (August 13, 2015, 7:04 PM EDT) -- U.S. biotech Baxalta Inc. wants Shire PLC to upgrade its unsolicited stock bid, valued around $30 billion, before it will agree to sit down and discuss a potential deal, Reuters reported Thursday. According to the report, Baxalta believes the Irish drugmaker's initial offer is not up to snuff, and needs the proposal to improve. Shire may actually be able to make something work, the report added, and more updates are expected in the coming weeks. The bid, lobbed early last week, saw Shire seeking a tie-up that would create a biotech giant focused on treatments for rare diseases....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!